1. Home
  2. PLUG vs ICUI Comparison

PLUG vs ICUI Comparison

Compare PLUG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plug Power Inc.

PLUG

Plug Power Inc.

HOLD

Current Price

$2.21

Market Cap

3.7B

Sector

Energy

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$157.01

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUG
ICUI
Founded
1997
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.6B
IPO Year
1999
1995

Fundamental Metrics

Financial Performance
Metric
PLUG
ICUI
Price
$2.21
$157.01
Analyst Decision
Hold
Strong Buy
Analyst Count
11
3
Target Price
$2.31
$169.00
AVG Volume (30 Days)
46.2M
282.9K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
47.01
100.62
EPS
N/A
1.20
Revenue
$709,919,000.00
$2,231,262,000.00
Revenue This Year
$26.67
N/A
Revenue Next Year
$8.09
$4.46
P/E Ratio
N/A
$128.68
Revenue Growth
12.90
N/A
52 Week Low
$1.39
$107.02
52 Week High
$4.58
$162.18

Technical Indicators

Market Signals
Indicator
PLUG
ICUI
Relative Strength Index (RSI) 26.84 62.91
Support Level $2.11 $139.88
Resistance Level $2.52 $160.09
Average True Range (ATR) 0.18 5.00
MACD -0.02 0.37
Stochastic Oscillator 6.36 76.17

Price Performance

Historical Comparison
PLUG
ICUI

About PLUG Plug Power Inc.

Plug Power Inc is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: